Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Seaside Therapeutics

Request full access

Drug treatments for neurodevelopmental disorders, including Fragile X syndrome and autism

Cambridge, United StatesFounded 2005Biotech & Life Sciences

About Seaside Therapeutics

Seaside Therapeutics was a biopharmaceutical company that focused on the development of therapeutics for neurodevelopmental disorders.

The company's primary objective was to create treatments for conditions such as Fragile X syndrome and autism spectrum disorders by targeting the underlying neurobiology of these conditions. Seaside Therapeutics aimed to translate scientific discoveries into clinical applications, with a specific focus on the mGluR5 and GABA-B pathways, which are believed to play a role in the synaptic dysfunction associated with these disorders.

The company is no longer in business.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2005
Headquarters
Cambridge, United States
Employees
13
Open positions
None listed
Dealroom signal
58.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Sep 2009 $30M $120M Undisclosed —
SPINOUT✓Other financing Sep 2005 $0 — Massachusetts Institute of Technology —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Seaside Therapeutics website traffic

Latest recorded traffic for Seaside Therapeutics is 170 monthly website visits. Seaside Therapeutics's team grew 0% over the past year.

Latest monthly visits170 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Seaside Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Seaside Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors1 additional known investor

  • Massachusetts Institute of Technology
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Seaside Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Seaside Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.